April 18, 2011

Kansas on Monday officially made the move from a paper tracking system for pseudoephedrine sales to the electronic tracking capabilities afforded through the National Precursor Log Exchange, according to an Associated Press report published Monday.

April 7, 2011

Elite Pharmaceuticals has begun shipping an appetite suppressant for reducing weight in obese patients, the company said Thursday.

March 30, 2011

Canadian drug maker Valeant Pharmaceuticals has proposed to buy Cephalon for $5.7 billion, Valeant said Tuesday.

March 25, 2011

There are three issues involving over-the-counter medicines today that have put the industry on the defensive, and all involve the question of appropriate access. Drug Store News examined each.

1. FLEXIBLE SPENDING ACCOUNTS The issue: The Patient Protection and Affordable Care Act required that FSA participants obtain a prescription for those OTCs incorporated into their health savings agenda.

March 17, 2011

The Arkansas House on Wednesday passed a bill that would restrict the behind-the-counter sale of pseudoephedrine to pharmacists only. In other words, pharmacy technicians no longer would be allowed to sell products containing PSE.

February 25, 2011

Watson Labs is hoping to be the first to market a generic version of a popular drug for attention deficit hyperactivity disorder.

February 23, 2011

Use of amphetamines could increase the risk of Parkinson’s disease, according to a new study.

February 4, 2011

The Food and Drug Administration has approved a generic weight-loss drug made by Elite Pharmaceuticals.

February 1, 2011

The Food and Drug Administration has turned down an application for an anti-obesity drug.

January 13, 2011

Nevada Sen. Sheila Leslie, D-Reno, is working with Carson City district attorney Neil Rombardo on introducing a bill to require a prescription for pseudoephedrine as a tool to cut down on illicit methamphetamine production, the Las Vegas Review-Journal reported Wednesday evening.

December 8, 2010

A Food and Drug Administration advisory committee has recommended approval for an investigational diet pill.

December 7, 2010

As a Food and Drug Administration advisory committee convenes to decide whether or not to approve a new drug for treating obesity, two nonprofit groups centered on the epidemic said more means of addressing it are needed.

November 30, 2010

A generic version of a drug indicated to treat attention deficit hyperactivity disorder has hit a roadblock.

November 14, 2010

The Food and Drug Administration has approved an attention deficit hyperactivity disorder drug for use...

October 24, 2010

The Food and Drug Administration has approved risk evaluation and mitigation strategies for two sleep...

October 7, 2010

Clinical trial data indicating an increased risk of heart attack and stroke has led to...

September 30, 2010

Mylan has launched a generic version of a common antidepressant, the company said Friday....

August 22, 2010

The industry-supported Combat Meth-amphetamine Enhancement Act, H.R. 2923, passed muster at the House Committee on...

July 20, 2010

Generic drug maker Caraco Pharmaceutical Labs has launched a generic antidepressant, Caraco said Wednesday....

July 20, 2010

Actavis has received regulatory approval from the Food and Drug Administration for a generic antidepressant,...

July 8, 2010

The Food and Drug Administration on Thursday warned that Que She, marketed as an herbal...

July 6, 2010

The Food and Drug Administration has approved a drug made by Shire for treating attention...

May 16, 2010

Electronic tracking or prescription-only? That’s the question that vexed Congressional leaders last month as they...

May 3, 2010

The Food and Drug Administration has approved Mylan’s generic version of a smoking-cessation drug, Mylan...